Lenderink, Timo <br/><br/>
Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.  [electronic resource] 

 -  Journal of the American College of Cardiology  Jan 2006 
 - 307-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-3597 
<br/><br/><label>Standard No.: </label>10.1016/j.jacc.2005.08.063  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Angina, Unstable--blood<br/>Antibodies, Monoclonal--therapeutic use<br/>Biomarkers--blood<br/>C-Reactive Protein--analysis<br/>CD40 Ligand--blood<br/>Creatine Kinase--blood<br/>Creatine Kinase, MB Form--blood<br/>Growth Substances--blood<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Multivariate Analysis<br/>Myocardial Infarction--blood<br/>Myocardial Ischemia--blood<br/>Placenta Growth Factor<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Predictive Value of Tests<br/>Pregnancy Proteins--blood<br/>Prognosis<br/>Proportional Hazards Models<br/>Randomized Controlled Trials as Topic<br/>Risk Assessment<br/>Troponin T--blood